Oral Ivermectin Versus Topical Permethrin to Treat Scabies in Children and Adults

PHASE3CompletedINTERVENTIONAL
Enrollment

1,092

Participants

Timeline

Start Date

January 19, 2016

Primary Completion Date

December 16, 2021

Study Completion Date

January 18, 2022

Conditions
Scabies
Interventions
DRUG

Ivermectin

oral ivermectin, 200μg/kg given at baseline and at day 10.

DRUG

Permethrin

topical permethrin 5% cream applied at baseline and at day 10.

Trial Locations (29)

21079

CHU de Dijon, Dijon

33000

CHU de Bordeaux Hôpital Pellegrin, Bordeaux

34295

CHU de Montpellier, Montpellier

35000

CHU de Rennes, Rennes

37044

CHRU de Tours, Tours

44093

CHU de Nantes, Nantes

49933

CHU d'Angers, Angers

69677

CHU de Lyon, Bron

71321

CHG de Chalon sur Saône, Chalon-sur-Saône

72037

CH du Mans, Le Mans

75935

AP-HP - Hôpital Robert Debré, Paris

83600

CHI de Fréjus, Fréjus

94010

CHU de Créteil - Hôpital Henry Mondor, Créteil

95107

CH d'Argenteuil, Argenteuil

97448

CHU de la Réunion, Saint-Pierre

06202

CHU de Nice, Nice

Unknown

APHP- Bobigny - Avicenne, Bobigny

CHU de Bordeaux - Saint André, Bordeaux

CHU de Brest, Brest

CHD Vendée, La Roche-sur-Yon

CH Le Havre, Le Havre

CHRU de Lille, Lille

AP-HM, Marseille

APHP Hôpital Cochin, Paris

CH de Périgueux, Périgueux

CHU de Reims, Reims

CHU de Rouen, Rouen

CHU de Saint-Etienne, Saint-Etienne

CHU de Pointe à Pitre, Pointe-à-Pitre

All Listed Sponsors
lead

University Hospital, Bordeaux

OTHER

NCT02407782 - Oral Ivermectin Versus Topical Permethrin to Treat Scabies in Children and Adults | Biotech Hunter | Biotech Hunter